World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
66
Citations
24637
World Ranking
1600
National Ranking
809

Richard Baer publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Richard Baer sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 124 publications — 24th percentile

24% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Richard Baer D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Baer sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 66 D-Index — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Richard Baer is affiliated with Columbia University in the United States and has contributed extensively to research in the fields of biochemistry, genetics, molecular biology, and medicine.

Their work spans various subfields including molecular biology, oncology, cancer research, electrical and electronic engineering, and immunology. The main topics covered by their research include DNA repair mechanisms, CRISPR and genetic engineering, PARP inhibition in cancer therapy, cancer-related molecular pathways, chromatin remodeling and cancer, peptidase inhibition and analysis, and integrated circuits and semiconductor failure analysis.

Baer has published in several scientific venues, with frequent contributions to:

  • Proceedings of the National Academy of Sciences
  • Cell Reports
  • Molecular Cell
  • Cell
  • Nature Communications

Their recent papers highlight investigations into molecular and cellular processes related to cancer and genome stability. These include:

  • REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps, 2021, Molecular Cell
  • SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion, 2024, Cell
  • Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy, 2023, Nature Communications
  • Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner, 2023, Proceedings of the National Academy of Sciences
  • CtIP-mediated DNA resection is dispensable for IgH class switch recombination by alternative end-joining, 2020, Proceedings of the National Academy of Sciences

Frequent collaborators in research include Alberto Ciccia, Shan Zha, Angelo Taglialatela, Foon Wu-Baer, and Zhengping Shao, indicating a consistent multidisciplinary research network.

Best Publications

  • Ferroptosis as a p53-mediated activity during tumour suppression

    Le Jiang;Ning Kon;Tongyuan Li;Shang–Jui Wang

  • DNA sequence and expression of the B95-8 Epstein—Barr virus genome

    R. Baer;R. Baer;A. T. Bankier;M. D. Biggin;P. L. Deininger

  • Human CtIP promotes DNA end resection

    Alessandro A. Sartori;Claudia Lukas;Julia Coates;Martin Mistrik

  • Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

    Muyang Li;Christopher L. Brooks;Foon Wu-Baer;Delin Chen

  • Tumor Suppression in the Absence of p53-Mediated Cell-Cycle Arrest, Apoptosis, and Senescence

    Tongyuan Li;Ning Kon;Le Jiang;Minjia Tan

  • Identification of a RING protein that can interact in vivo with the BRCA1 gene product.

    Leeju C. Wu;Zhuo Wei Wang;Julia Tsou Tsan;Monique A. Spillman

  • The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression

    Xin Yu;Leeju C. Wu;Anne M. Bowcock;Ami Aronheim

  • Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia.

    Lamorna Brown;Jiin Tsuey Cheng;Qi Chen;Michael J. Siciliano

  • Diversity and rearrangement of the human T cell rearranging γ genes: nine germ-line variable genes belonging to two subgroups

    M.-P. LeFranc;A. Forster;R. Baer;M.A. Stinson

  • A forward chemical genetic screen reveals an inhibitor of the Mre11-Rad50-Nbs1 complex

    Aude Dupré;Louise Boyer-Chatenet;Louise Boyer-Chatenet;Rose M Sattler;Ami P Modi

  • The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix-loop-helix protein.

    Q. Chen;J.T. Cheng;L.H. Tasi;N. Schneider

  • The BRCA1/BARD1 Heterodimer Assembles Polyubiquitin Chains through an Unconventional Linkage Involving Lysine Residue K6 of Ubiquitin

    Foon Wu-Baer;Karen Lagrazon;Wei Yuan;Richard Baer

  • The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

    Richard Baer;Thomas Ludwig

  • DNA double-strand break repair pathway choice and cancer.

    Tomas Aparicio;Richard Baer;Jean Gautier

  • Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma.

    T. H. Rabbitts;P. H. Hamlyn;R. Baer

  • Specific in vivo association between the bHLH and LIM proteins implicated in human T cell leukemia.

    Isobel Wadman;Jinxing Li;Robert O. Bash;Alan Forster

  • Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice.

    R. C. Larson;I. Lavenir;T. A. Larson;R. Baer

  • BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair.

    Samuel F. Bunting;Elsa Callén;Marina L. Kozak;Jung Min Kim

  • The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells

    V E Valge-Archer;H Osada;A J Warren;A Forster

  • BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP.

    Xiaochun Yu;Shuang Fu;Maoyi Lai;Richard Baer

Frequent Co-Authors

Thomas Ludwig
Thomas Ludwig Columbia University
Jean Gautier
Jean Gautier Columbia University
Maria Jasin
Maria Jasin Memorial Sloan Kettering Cancer Center
Melanie H. Cobb
Melanie H. Cobb The University of Texas Southwestern Medical Center
Anne M. Bowcock
Anne M. Bowcock Icahn School of Medicine at Mount Sinai
Wei Gu
Wei Gu Columbia University
André Nussenzweig
André Nussenzweig National Institutes of Health
William M. Crist
William M. Crist University of Oklahoma
Max E. Gottesman
Max E. Gottesman Columbia University Medical Center
Tanya T. Paull
Tanya T. Paull The University of Texas at Austin

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in molecular biology or related biomedical sciences, exploring online nursing and healthcare degrees can open diverse career opportunities. For those with an associate degree in nursing, pursuing asn to np bridge programs allows you to quickly move from registered nurse roles to advanced nurse practitioner positions.

Those who do not have a nursing background can look into msn direct entry programs online. These programs are designed to help non-nurses enter the nursing profession with a master's-level education, making them a strong option for science majors seeking new directions.

Choosing the right school is also an important consideration. Comparing accredited programs—such as evaluating which school is better, snhu vs wgu—ensures you pick a reputable university that suits your needs, budget, and learning style.

For current registered nurses looking to advance, the bsn to msn pathway offers flexible and affordable options to transition into leadership or specialized roles. Exploring these pathways can help you connect a foundation in molecular biology with impactful healthcare careers.

Best Scientists Citing Richard Baer

Trending Scientists

Recently Published Articles